... reason is for the
PH1025 I have never seen a study that shows after market test or anything to say how many men or and woman are on any drug but in this little post i found it does say it works the same for both... this is all i could fine and it was on this site hope this helps some so you can figure it out...
Age and Gender Effects
In a multiple-dose (8 days of treatment) study involving 32 subjects, there was no difference in the pharmacokinetics of ziprasidone between men and women or between elderly (> 65 years) and young (18 to 45 years) subjects. Additionally, population pharmacokinetic evaluation of patients in controlled trials has revealed no evidence of clinically significant age or gender-related differences in the pharmacokinetics of ziprasidone. Dosage modifications for age or gender are, therefore, not recommended. THIS is the best i can do... Chuck1957
- Ziprasidone Information for Consumers
- Ziprasidone Information for Healthcare Professionals (includes dosage details)
- Side Effects of Ziprasidone (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 25 Aug 2009 • 1 answer
Posted 8 Oct 2009 • 1 answer
Posted 17 Jun 2011 • 6 answers
Posted 31 Jul 2014 • 3 answers
Posted 25 Jul 2017 • 2 answers